Diagnostics of gyneacological diseases, especially epithelial ovarian cancer
Abstract:
The present disclosure relates to methods and a kit for diagnosing, prognosing and/or monitoring a gynaecological disease, especially epithelial ovarian cancer, on the basis of altered glycosylation pattern of CA125. More specifically, said altered glycosylation pattern relates to that recognizable by MGL.
Information query
Patent Agency Ranking
0/0